AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-160184695/teva-gains-final-us.html" title="Facts and information about Teva gains final US approval for generic Aciphex.(Teva Pharmaceutical Industries Ltd.)(Brief article)">Teva gains final US approval for generic Aciphex.(Teva Pharmaceutical Industries Ltd.)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.
Frequently asked questions about RSS feeds
Teva gains final US approval for generic Aciphex.(Teva Pharmaceutical Industries Ltd.)(Brief article)
The US Food and Drug Administration has granted final approval for Israeli firm Teva Pharmaceutical Industries' Abbreviated New Drug Application for rabeprazole sodium delayed-release tablets, 20mg.
Teva's rabeprazole product is the AB-rated generic equivalent of Eisai's acid pump inhibitor Aciphex, which had annual sales of ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- A company review of Teva Pharmaceutical Industries Ltd including information on...
- Press release article from: M2 Presswire November 2, 2005 700+ words
...A company review of Teva Pharmaceutical Industries Ltd including information...announced the addition of Teva Pharmaceutical Industries Ltd Deals Briefing...offering Description Teva Pharmaceutical Industries Ltd Deals briefing...
- Trade Alert for Teva Pharmaceutical Industries Ltd.
- Press release article from: M2 Presswire June 14, 2007 700+ words
...Biotech News: Trade Alert for Teva Pharmaceutical Industries Ltd(C)1994-2007 M2 COMMUNICATIONS...14062007 Trade Alert for Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) Teva Pharmaceutical Industries Limited engages in the development...
- Current Research on Teva Pharmaceutical Industries Ltd.
- Press release article from: M2 Presswire June 12, 2007 700+ words
...News: Current Research on Teva Pharmaceutical Industries Ltd(C)1994-2007 M2 COMMUNICATIONS...12062007 Current Research on Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) Teva Pharmaceutical Industries Limited engages in the development...
- Analysis of Teva Pharmaceutical Industries Ltd.
- Press release article from: M2 Presswire June 22, 2007 700+ words
...Biotech News: Analysis of Teva Pharmaceutical Industries Ltd(C)1994-2007 M2 COMMUNICATIONS...RDATE:22062007 Analysis of Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) Teva Pharmaceutical Industries Limited engages in the development...
- A Company Review of Teva Pharmaceutical Industries Ltd Including Information on...
- Press release article from: Business Wire November 17, 2005 700+ words
...announced the addition of Teva Pharmaceutical Industries Ltd Deals Briefing...offering. Description Teva Pharmaceutical Industries Ltd Deals briefing...the 75 deals made by Teva Pharmaceutical Industries Ltd and its subsidiaries...
- Teva Pharmaceutical Industries, Ltd. and sanofi-aventis Today Announced...
- Press release article from: M2 Presswire June 6, 2007 700+ words
...Headline Maker: Teva Pharmaceutical Industries, Ltd. and sanofi...our research team. Teva Pharmaceutical Industries, Ltd. (NASDAQ...exchanges offer. June 6 - Teva Pharmaceutical Industries, Ltd. and sanofi...
- Introduces Teva Pharmaceutical Industries to our Bluechips Watch List.
- Press release article from: M2 Presswire January 29, 2008 700+ words
...Market Review: Introduces Teva Pharmaceutical Industries to our Bluechips Watch List...opens with new prospects is Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA). Teva Pharmaceutical Industries Ltd., headquartered in Israel...
- Introduces Teva Pharmaceutical Industries Ltd. to our Bluechips Watch List.
- Press release article from: M2 Presswire January 16, 2008 700+ words
...Stock Targets: Introduces Teva Pharmaceutical Industries Ltd. to our Bluechips Watch...opens with new prospects is Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA). Teva Pharmaceutical Industries Ltd., headquartered in Israel...